Literature DB >> 15519280

Oncogenic transformation of human cells: shortcomings of rodent model systems.

Tsuyoshi Akagi1.   

Abstract

Long-standing difficulties in the in vitro transformation of human cells have been overcome. Using telomerase, several successful oncogene-mediated transformations of human cells have been reported and the following cellular requirements for human cell transformation have been proposed: the maintenance of telomere sequences, the inactivation of Rb and p53 pathways, the perturbation of protein phosphatase 2A (PP2A) and the expression of activated Ras. Even when all of these requirements are fulfilled, however, the transformed phenotypes of human cells seem to be much less malignant than those of rodent cells meeting the same requirements. This suggests the existence of undefined cell-autonomous mechanisms that render human cells resistant to malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15519280     DOI: 10.1016/j.molmed.2004.09.001

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  13 in total

1.  Inducible expression of chimeric EWS/ETS proteins confers Ewing's family tumor-like phenotypes to human mesenchymal progenitor cells.

Authors:  Yoshitaka Miyagawa; Hajime Okita; Hideki Nakaijima; Yasuomi Horiuchi; Ban Sato; Tomoko Taguchi; Masashi Toyoda; Yohko U Katagiri; Junichiro Fujimoto; Jun-Ichi Hata; Akihiro Umezawa; Nobutaka Kiyokawa
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

2.  Regulation of G1 Cell Cycle Progression: Distinguishing the Restriction Point from a Nutrient-Sensing Cell Growth Checkpoint(s).

Authors:  David A Foster; Paige Yellen; Limei Xu; Mahesh Saqcena
Journal:  Genes Cancer       Date:  2010-11

Review 3.  A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.

Authors:  Craig L Parfett; Daniel Desaulniers
Journal:  Int J Mol Sci       Date:  2017-06-01       Impact factor: 5.923

4.  Overexpression of SKI oncoprotein leads to p53 degradation through regulation of MDM2 protein sumoylation.

Authors:  Boxiao Ding; Yin Sun; Jiaoti Huang
Journal:  J Biol Chem       Date:  2012-03-12       Impact factor: 5.157

5.  p27kip1 protein levels reflect a nexus of oncogenic signaling during cell transformation.

Authors:  Jeffrey P Miller; Nancy Yeh; Christoph P Hofstetter; Doruk Keskin; Andrew S Goldstein; Andrew Koff
Journal:  J Biol Chem       Date:  2012-04-17       Impact factor: 5.157

Review 6.  Principles of adoptive T cell cancer therapy.

Authors:  Carl H June
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

7.  Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes.

Authors:  Muy-Teck Teh; Emilios Gemenetzidis; Tracy Chaplin; Bryan D Young; Michael P Philpott
Journal:  Mol Cancer       Date:  2010-02-26       Impact factor: 27.401

8.  Telomerase reverse transcriptase expression elevated by avian leukosis virus integration in B cell lymphomas.

Authors:  Feng Yang; Rena R Xian; Yingying Li; Tatjana S Polony; Karen L Beemon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-16       Impact factor: 11.205

9.  Cyclooxygenase-2 induces neoplastic transformation by inhibiting p53-dependent oncogene-induced senescence.

Authors:  Hyeon Ju Lee; So Ra Kim; Yu-Jin Jung; Jeong A Han
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

10.  Salient features of mesenchymal stem cells-implications for Ewing sarcoma modeling.

Authors:  Michael J Monument; Nicholas M Bernthal; R Lor Randall
Journal:  Front Oncol       Date:  2013-02-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.